# Hyaluronidase for Trigger Point Injection in Myofascial Pain Syndrome

> **NCT02293083** · NA · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 61 (actual)

## Conditions studied

- Myofascial Pain Syndrome

## Interventions

- **DRUG:** trigger point injection

## Key facts

- **NCT ID:** NCT02293083
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-04
- **Final completion:** 2011-05
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2014-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02293083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02293083, "Hyaluronidase for Trigger Point Injection in Myofascial Pain Syndrome". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02293083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*